• Mashup Score: 2
    ONCO DVT: Edoxaban For 12 Months vs. 3 Months in Patients With Cancer and DVT - American College of Cardiology - 8 month(s) ago

    In patients with cancer and isolated distal deep vein thrombosis (DVT), 12 months of anticoagulation therapy with edoxaban was superior to a duration of three months in terms of reducing thrombotic events, according to findings from the ONCO DVT trial presented at ESC Congress 2023 and simultaneously published in Circulation. The trial randomized a total of 604 patients with active cancer and newly diagnosed isolated distal DVT to either 12 months of edoxaban or three months of edoxaban. Edoxaban was

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      In patients w/ #cancer and isolated distal DVT, 12 months of #anticoagulation therapy with edoxaban was superior to 3 months in terms of reducing thrombotic events, based on findings from ONCO DVT #ESCCongress. https://t.co/c5zb1ZE2jq https://t.co/iaRCXUHpzb

  • Mashup Score: 1
    Intravenous Dabigatran Provides Adequate Anticoagulation for Cardiopulmonary Bypass Using a Rabbit Model - 11 month(s) ago

    The hypothesis that dabigatran would provide sufficient anticoagulation for cardiopulmonary bypass was tested in a first-use, proof-of-concept study using a rabbit model of cardiopulmonary bypass that included a comparison group receiving heparin. The dabigatran loading dose and maintenance infusions were designed after first determining its pharmacokinetics in rabbits and the target…

    Source: American Society of Anesthesiologists
    Categories: Anesthesiology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASALifeline
      ASALifeline

      In a first-use, proof-of-concept study, researchers using a rabbit CPB model showed that #dabigatran provides acceptable #anticoagulation similar to heparin to prevent thrombosis. Read the new article published in @_Anesthesiology: https://t.co/iFCyHjygqM https://t.co/vsIotk2Jc2

Load More